A new version of OASIS rolled out in April 2026, removing the COVID-19 vaccine question and adding a handful of other updates to the assessment. On its own, that might sound like a minor administrative change. In practice, any change to OASIS creates a window where documentation accuracy is most likely to slip, simply because clinicians are learning a slightly different version of a form they've filled out thousands of times.

For an organization like Elara Caring, with clinical teams spread across 200-plus locations and two service lines, that window matters more than it would for a smaller, single-site agency. A documentation gap that shows up in one region during a transition period can go unnoticed for weeks if there's no consistent way to see it.

Where documentation gaps tend to hide

Most OASIS accuracy problems aren't dramatic. They show up in specific item types: GG and functional items, M-item ADL responses, and risk assessment items, where a clinician's judgment call doesn't quite match how the item is supposed to be scored. Individually, these look like small inconsistencies. Across a large clinical workforce, they add up into real variation in how accurately a patient's functional status gets captured, which affects everything downstream, from care planning to quality reporting to reimbursement.

The challenge for clinical leadership is visibility. Without a clear view into which specific items are driving inaccuracy, and which clinicians might need support on which items, the usual response is broad retraining: everyone reviews everything, whether they need to or not. That's a lot of clinician time spent on documentation review instead of patient care, and it doesn't always target the actual gap.

Targeted support instead of blanket retraining

Olli's clinician-specific accuracy scorecard is built around exactly this problem. It measures OASIS answers, GG and functional items, M-item ADL responses, and risk assessment items, and shows clinical leadership where accuracy is strong and where it needs attention, by clinician and by item type. That means training conversations can be specific: "here's the item where accuracy has room to improve," instead of a general refresher that may or may not be relevant to a particular clinician's actual documentation patterns.

That kind of visibility becomes especially useful during regulation changes. Instead of waiting to find out after the fact whether accuracy held up through the transition, clinical leadership has a way to see it happening in real time and step in early.

Protecting accuracy without adding to clinician workload

None of this should mean more work for clinicians. Olli's certified experts touch every chart, catching and correcting documentation issues before they become compliance exposure or reimbursement risk, so the burden of protecting accuracy doesn't fall on already-stretched clinical staff. Clinicians get more time with patients. Clinical leadership gets a clear, item-level view of where accuracy stands. And documentation stays reliable through changes like the OASIS update, instead of becoming a source of scramble every time CMS revises the form.

A 30-day pilot gives clinical leadership a direct look at what that accuracy and visibility looks like on real charts, with no obligation attached. It's worth seeing before the April transition, not after.